UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | R | S | T
Number of items: 50.

A

Ajzensztejn, D; Hegde, V; Lee, SM; (2006) Tumour lysis syndrome following treatment with standard second-line docetaxel for non-small cell lung cancer. Journal of Clinical Oncology , 24 (15) 2389 - 2391.

Arkenau, T; Cunningham, D; Mita, MM; Ochoa, L; Rowinsky, EK; Kuhn, J; ... Tolcher, AW; + view all (2006) A Phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense, G3139) and irinotecan in patients with metastatic colorectal cancer. Advances in Gastrointestinal Cancers , 4 (1) 20 - 21.

Arnould, S; Spanswick, VJ; Macpherson, JS; Hartley, JA; Thurston, DE; Jodrell, DI; Guichard, SM; (2006) Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. Mol Cancer Ther , 5 (6) 1602 - 1609. 10.1158/1535-7163.MCT-06-0018.

B

Begent, R; (2006) Developing Integrated Informatics Platform for Cancer Research. In: Nagl, S, (ed.) Cancer Bioinformatics: From Therapy Design to Treatment. (45 - 55). John Wiley & Sons: Chichester.

Beresford, MJ; Chin, Y; Burcombe, Y; Ah-See, M; Makris, A; (2006) Clinical response assessment after 2 cycles of neoadjuvant chemotherapy for primary breast cancer fails to predict for final clinical response, but does predict for pathological complete response. In: Journal of Clinical Oncology. (pp. 44S - 44S).

Beresford, MJ; Harris, AL; Ah-See, M; Daley, F; Padhani, AR; Makris, A; (2006) The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer. BRITISH JOURNAL OF CANCER , 95 (12) 1683 - 1688.

Beresford, MJ; Wilson, GD; Makris, A; (2006) Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Research , 8 (6)

Bilancio, A; Okkenhaug, K; Camps, M; Emery, JL; Ruckle, T; Rommel, C; Vanhaesebroeck, B; (2006) Key role of the p110 delta isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110 delta function in B cells. BLOOD , 107 (2) 642 - 650. 10.1182/blood.2005-07-3041.

Buchmueller, K; Bailey, S; Matthews, D; Register, J; Bruce, CD; O'Hare, C; ... Lee, M; + view all (2006) Molecular recognition of polyamides with DNA: A study on the strong binding of f-ImPyIm to its cognate DNA, ACGCGT. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. 678 - ?).

Buffa, FM; Bentzen, SM; Atasoy, BM; Daley, FM; Richman, PI; Dische, S; ... Saunders, MI; + view all (2006) The response of head and neck tumours to radiotherapy may be influenced by the interaction between cell proliferation and vascularization. In: RADIOTHERAPY AND ONCOLOGY. (pp. S65 - S66).

Burcombe, R; Wilson, GW; Dowsett, M; Khan, I; Richman, PI; Daley, F; ... Makris, A; + view all (2006) Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Research , 8 (3) R31 - ?. 10.1186/bcr1508.

Burton, C; Linch, D; Hoskin, P; Milligan, D; Dyer, MJS; Hancock, B; ... Cunningham, D; + view all (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. BRITISH JOURNAL OF CANCER , 94 (6) 806 - 813.

C

Caroline, R; (2006) I was saved from death by cells harvested from my bones. The Daily Mail

Cave, J; Davis, B; Lee, SM; Jones, A; (2006) A randomised controlled trial comparing symptom-based and tumour-based teaching for undergraduates medical students. In: (Proceedings) 2006 NCRI Cancer Conference, Birmingham.. (pp. 192 - ?). Annals of Oncology

Chang, JC; Makris, A; Hilsenbeck, SJ; Hackett, JR; Jeong, J; Liu, M; ... Shak, S; + view all (2006) Gene expression profiles in formalin-fixed, paraffin-embedded (FFPE) core biopsies predict docetaxel chemosensitivity. In: Journal of Clinical Oncology. (pp. 12S - 12S).

Channel, 5N; (2006) Cancer drug battle. UNSPECIFIED

Chin, Y; Ravichandran, D; Makris, A; (2006) Exemestane after non-steroidal aromatase inhibitors for post-menopaual women with advanced breast cancer. In: european Journal of Cancer. (pp. 167 - ?).

Cleator, S; Makris, A; Powles, T; (2006) Response to letter "Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy" by Bogaerts et al. (Ann Oncol 2006; 17 : 352-353). UNSPECIFIED

D

Dische, S; Rojas, A; Saunders, M; (2006) What can be learnt from a final follow up study of the chart pilot study? In: Radiotherapy & Oncology. (pp. S131 - S131).

Donovan, E; Coles, C; Westbury, C; Yarnold, J; (2006) Breast. In: External Beam Therapy. Oxford University Press

E

El, EE; Dearling, J; Huhalov, A; Robson, P; Neri, D; van, DGA; ... Pedley, RB; + view all (2006) Targeting the tumour vasculature: therapeutic efficacy of a 131I-labeled antibody against the ED-B domain of fibronectin. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 63 - ?).

El, EE; Dearling, J; Huhalov, A; Robson, P; Neri, D; van, DGA; ... Pedley, RB; + view all (2006) Targeting tumour vasculature in human colorectal xenografts using an antibody against the extra-domain B of fibronectin. BACR/BMS Tumour vasculature: New targets and Therapies. In: Angiogenesis. (pp. 18 - ?).

F

Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; ... Vanhaesebroeck, B; + view all (2006) Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature , 441 (7091) 366 - 370. 10.1038/nature04694.

G

Glynne-Jones, R; Grainger, J; Harrison, M; Ostler, P; Makris, A; (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? BRITISH JOURNAL OF CANCER , 94 (3) 363 - 371.

H

Hamaguchi, A.; (2006) Molecular and cellular pharmacology of novel pyrrolo [2,1-c] [1,4] diazepine-based anticancer agents. Doctoral thesis, University of London. Green open access
file

Harland, SJ; Daugaard, G; Horwich, A; Mead, GM; Fossa, SD; Sokal, M; ... National, CRITCCSG; + view all (2006) The familial influence on bilateral testicular germ cell cancer: Medical Research Council study TER2. In: Journal of Clinical Oncology. (pp. 239S, 4590 - ?).

Hopper, C.; (2006) Photodynamic therapy for the treatment of oral cancer. Doctoral thesis, University of London. Green open access
file

J

Julia, LS; (2006) You Don't Have to Smoke to Get Lung Cancer. Sunday Telegraph, Stella Magazine

K

Kaufmann, M; Hortobagyi, GN; Goldhirsch, A; Scholl, S; Makris, A; Valagussa, P; ... von Minckwitz, G; + view all (2006) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update. JOURNAL OF CLINICAL ONCOLOGY , 24 (12) 1940 - 1949.

Khoja, L; Mulyati, M; Lee, SM; (2006) Secondline chemotherapy in NSCLC. Lung Cancer in Practice , 3 (1) 6 - 7.

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shabakhti, H; ... Chester, KA; + view all (2006) Clearance mechanism of a mannoseylated antibody enzyme fusion protein used in experimental cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 65 - ?).

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shahbakhti, H; ... Chester, KA; + view all (2006) Clearance Mechanism Of A Mannosylated Antibody-Enzyme Fusion Protein Used In Experimental Cancer Therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

L

Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib therapy in brain metastases from recurrent NSCLC. Thorax , 61 (1) 91 - ?.

Last, K; Maharaj, L; Perry, J; Strauss, S; Fitzgibbon, J; Lister, TA; Joel, S; (2006) The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol , 17 , Article 5.

Le, NM; Sielaff, AM; Cooper, AJ; Mackay, H; Brown, T; Kotecha, M; ... Hartley, JA; + view all (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. Bioorganic and Medicinal Chemistry Letters , 16 (24) 1661 - 1664.

Lipton, L.R.; (2006) Familial colorectal cancer and polyposis genes, pathways and predictions. Doctoral thesis, University of London. Green open access
file

Louise, J; (2006) Thalidomide makes a comeback-but at what cost? Morning Star

M

Masterson, LA; Spanswick, VJ; Hartley, JA; Begent, RH; Howard, PW; Thurston, DE; (2006) Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. Bioorganic and Medicinal Chemistry Letters , 16 (2) 252 - 256. 10.1016/j.bmcl.2005.10.017.

N

Ng, QS; Goh, V; Fichte, H; Klotz, E; Fernie, P; Saunders, MI; ... Padhani, AR; + view all (2006) Lung cancer perfusion at multi-detector row CT: Reproducibility of whole tumor quantitative measurements. RADIOLOGY , 239 (2) 547 - 553.

R

Rades, D; Stalpers, LJA; Veninga, T; Hoskin, PJ; (2006) Spinal reirradiation after short-course RT for metastatic spinal cord compression. International Journal of Radiation Oncology Biology Physics , 63 (3) 872 - 875.

Ranson, R; Middleton, MR; Bridgewater, J; Lee, SM; Dawson, M; Jowle, D; ... Margison, GP; + view all (2006) Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA alkyltransferas: Phase 1 safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumours. Clinical Cancer Research , 12 (5) 1577 - 1584.

Ravn, P; Patel, A; Andre, M; Bicknell, R; Begent, R; Pedley, B; ... Meyer, T; + view all (2006) Generation of Antibodies to Magic Roundabout 4, Robo4 using Phage Display. In: (Proceedings) NCRI Cancer Conference Proceedings.

S

Saunders, MI; Rojas, A; (2006) Burning issues in CERT. In: RADIOTHERAPY AND ONCOLOGY. (pp. S19 - S19).

Shanley, S; McReynolds, K; Ardern, JA; Ahern, R; Fernando, I; Yarnold, J; ... Easton, DAER; + view all (2006) Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clinical Cancer Research , 1 (12) 7025 - 7032.

Shanley, SBKS; S Evans G Tutt, AH; S Powles, TASA; R Easton D and Eeles, R; (2006) Acute Chemotherapy related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the UK. Clinical Cancer Research

Short, S; (2006) UNSPECIFIED In: (Proceedings) 3rd International Conference on Translational Research and Preclinical Strategies in Radiation Oncology.

Short, S; (2006) BBC 6 O'Clock news. UNSPECIFIED

Sizer, B; Makris, A; Barone, C; Mainwaring, P; Eggleton, P; (2006) QoL and resource use analysis of tegafur-uracil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study. In: Journal of Clinical Oncology. (pp. 178S - 178S).

T

Thirlwell, C.; (2006) Mechanisms of colorectal tumorigenesis associated with Mut-Y (MYH) deficiency and identification of novel predisposition genes in the multiple adenoma phenotype. Doctoral thesis, University of London. Green open access
file

Tolner, B; Hillyer, T; Smith, L; Begent, RHJ; Contreras, R; Chester, KA; (2006) A Recombinant Antibody-Enzyme Fusion Protein Produced in Pichia Pastoris in Compliance with EU Clinical Trials Directive for Phase I/II Cancer Trials. In: (Proceedings) NCRI Cancer Conference Proceedings.

This list was generated on Sat Feb 28 07:34:37 2015 GMT.